Verition Fund Management
TXG icon

Verition Fund Management’s 10x Genomics TXG Stock Holding History

Verition Fund Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-107,957
Closed -$1.25M – 4004
2025
Q2 		$1.25M Sell
107,957
-83,686
-44% -$763K 0.01% 2299
2025
Q1 		$1.67M Buy
+191,643
New +$2.42M 0.01% 1707
2024
Q4 		– Sell
-13,860
Closed -$313K – 3535
2024
Q3 		$313K Buy
13,860
+2,890
+26% +$59.7K ﹤0.01% 2616
2024
Q2 		$213K Buy
+10,970
New +$287K ﹤0.01% 2556
2023
Q4 		– Sell
-10,000
Closed -$413K – 2693
2023
Q3 		$413K Buy
+10,000
New +$520K ﹤0.01% 1546
2021
Q3 		– Sell
-2,116
Closed -$414K – 2318
2021
Q2 		$414K Buy
+2,116
New +$383K ﹤0.01% 1182

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Verition Fund Management's TXG Position: Q3 2025 in Review

Verition Fund Management sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 107,957 shares — an estimated $1.25M sold.

Verition Fund Management first reported a position in TXG in Q2 2021 and held it in 6 quarters. The position peaked at $1.67M in Q1 2025. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • Verition Fund Management reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 107,957 10x Genomics shares in Q3 2025, an estimated $1.25M.
  • Verition Fund Management first reported a position in 10x Genomics in Q2 2021 and held it in 6 quarters.
  • Verition Fund Management's 10x Genomics position peaked at $1.67M in Q1 2025.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.